Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-15-060960
Filing Date
2015-08-19
Accepted
2015-08-19 16:04:27
Documents
1
Period of Report
2015-08-11

Document Format Files

Seq Description Document Type Size
1 3 a3.html 3  
1 3 a3.xml 3 3910
  Complete submission text file 0001104659-15-060960.txt   5245
Mailing Address 215 FIRST STREET CAMBRIDGE MA 02142
Business Address 215 FIRST STREET CAMBRIDGE MA 02142 617-374-7580
Blueprint Medicines Corp (Issuer) CIK: 0001597264 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address BLUEPRINT MEDICINES CORP. 214 FIRST STREET, SUITE 340/350 CAMBRIDGE MA 02142
Business Address
Landsittel Michael (Reporting) CIK: 0001651036 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37359 | Film No.: 151064061